The FDA has approved the emergency use of DarioHealth’s (NASDAQ:DRIO) blood glucose testing strips and smartphone-connected device for hospitalized diabetics who have COVID-19.
Patients can self-test their blood sugar levels with their own device or the hospital can issue one to them upon admission.
https://seekingalpha.com/news/3570063-dariohealth-up-11-on-fda-nod-on-self-check-glucose-meter-in-hospitals
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.